Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study (Isotoxic-IMRT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01836692 |
|
Recruitment Status :
Completed
First Posted : April 22, 2013
Last Update Posted : October 31, 2018
|
Sponsor:
Prof Corinne Faivre-Finn
Collaborators:
Cancer Research UK
British Lung Foundation
Sheffield Teaching Hospitals NHS Foundation Trust
Belfast Health and Social Care Trust
The Leeds Teaching Hospitals NHS Trust
Cambridge University Hospitals NHS Foundation Trust
Royal Marsden NHS Foundation Trust
East and North Hertfordshire NHS Trust
Information provided by (Responsible Party):
Prof Corinne Faivre-Finn, The Christie NHS Foundation Trust
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | October 2016 |
| Actual Study Completion Date : | June 2018 |